Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup

Sep.20
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024

Key Points

  • Imperial acquired 100% of Yoik for an initial SEK 515 million, with Latham & Watkins and KPMG on the buyer side and PwC and TM & Partners advising Yoik.
  • KPMG also advised Imperial on its 2026 acquisition of Black Buffalo, making it the recurring adviser across Imperial's two disclosed modern oral acquisitions this year.
  • Imperial's Black Buffalo deal also involved Morgan Stanley and White & Case for the buyer, with Goldman Sachs and Paul, Weiss advising the seller.
  • PwC supported KT&G's acquisition of Another Snus Factory from target screening through due diligence, structuring, negotiations and closing, and later appeared among the advisers to Yoik.
  • Imperial data citing Euromonitor put the global modern oral nicotine delivery category at around 23.5 billion pouches and £8.8 billion in retail sales in 2024.

2Firsts

September 20, 2026

Imperial Brands' September acquisition of Swedish modern oral nicotine company Yoik Group AB has disclosed a broader lineup of professional-services firms working across the transaction.

Imperial acquired 100% of Yoik for an initial SEK 515 million, or approximately £39.8 million, with an additional deferred payment linked to performance over the following two years.

Yoik's Helwit brand held about 3.4% of Sweden's modern oral market over the previous 12 months. Imperial said the deal would more than double its existing share of the category in Sweden, which represents more than 40% of European modern oral nicotine volumes.

Imperial was advised by Latham & Watkins and KPMG, while Yoik was advised by PwC and TM & Partners.

Latham and KPMG Join Imperial's Yoik Adviser Team

Latham said its London corporate team led the Yoik transaction, supported by lawyers covering tax, employment, data and technology transactions, regulatory matters, antitrust, sanctions, ESG and real estate.

The firm's publicly disclosed work for Imperial extends beyond the acquisition. Imperial's 2026 global medium-term note prospectus also names Latham & Watkins as legal adviser to the issuers and guarantor on English and U.S. law.

KPMG, meanwhile, also appeared in another Imperial modern oral transaction earlier this year.

In May, Imperial acquired U.S. modern oral company Black Buffalo. The buyer was advised by Morgan Stanley, KPMG and White & Case, while Black Buffalo was advised by Goldman Sachs and Paul, Weiss.

Black Buffalo sells long-cut and pouch products aimed primarily at adult users of traditional moist smokeless tobacco. Its product positioning is therefore not identical to a nicotine-pouch brand such as Helwit, making the two transactions more appropriately comparable as part of Imperial's broader modern oral expansion.

KPMG Appears in Both Imperial Modern Oral Acquisitions

Across Imperial's publicly disclosed Black Buffalo and Yoik acquisitions in 2026, the law firms and investment banks changed while KPMG appeared on the buyer side of both transactions.

TransactionAsset / BrandMarketBuyerBuyer AdvisersSeller Advisers
Yoik Group / HelwitNicotine pouchesSwedenImperial BrandsLatham & Watkins, KPMGPwC, TM & Partners
Black BuffaloModern oralU.S.Imperial BrandsMorgan Stanley, KPMG, White & CaseGoldman Sachs, Paul, Weiss
Another Snus Factory / LOOPNicotine pouchesSwedenKT&G acquisition, with an Altria subsidiary taking an equity interestPwC provided buy-side support to KT&GNot fully disclosed in the public materials reviewed

Imperial's acquisition announcements do not specify whether KPMG's work covered financial due diligence, tax, valuation or another advisory function.

The firm's presence in both transactions nevertheless makes it the recurring external adviser identified across Imperial's two disclosed modern oral acquisitions in 2026.

PwC Supports ASF Deal From Target Screening to Closing

PwC appears on the seller side of the Yoik transaction, while its work on another Swedish nicotine-pouch acquisition was broader.

In 2025, KT&G acquired Swedish nicotine-pouch company Another Snus Factory, with an Altria subsidiary taking an equity interest under the companies' investment arrangement. ASF owns the LOOP brand.

PwC said its Korean team became involved early in KT&G's process, reviewing a range of NGP businesses across Europe and identifying ASF as an acquisition target.

After target identification, PwC's work covered acquisition strategy, due diligence, transaction structuring, negotiations and closing, with teams in Korea and Sweden working on the transaction.

PwC also said the process involved a competitive bidding environment with several global investors, while multiple global tobacco companies had been considered as potential co-investors.

PwC therefore appears in at least two transactions involving Swedish nicotine-pouch assets: on the buy side for KT&G's ASF transaction and among the seller advisers in Yoik's sale to Imperial.

Global Modern Oral Retail Sales Reached About £8.8 Billion in 2024

The acquisitions are taking place in a category that has developed into a multibillion-pound consumer market.

Imperial's 2026 global medium-term note prospectus, citing Euromonitor data, said approximately 23.5 billion modern oral nicotine delivery pouches were sold globally in 2024, representing an estimated £8.8 billion in retail sales.

The largest markets by category value included:

  • the United States at approximately £6.9 billion;
  • Sweden and Denmark combined at approximately £0.8 billion.

The figures show that category value remains heavily concentrated in a small number of markets, led by the United States, while Sweden is the largest modern oral market in Europe.

Imperial also said most category growth over the next several years is expected to come from the U.S.

Cross-Border Deals Use Different Adviser Combinations

The Black Buffalo, Yoik and ASF transactions used different combinations of external advisers.

Imperial's Black Buffalo acquisition brought together international investment banks, a Big Four firm and global law firms. Its Yoik deal paired Latham and KPMG on the buyer side with PwC and Swedish firm TM & Partners for the seller.

The ASF transaction also shows that Big Four involvement in nicotine-pouch M&A can extend beyond conventional due diligence to target screening, acquisition strategy, structuring and negotiations.

Imperial has completed two modern oral acquisitions in 2026 through Black Buffalo and Yoik, while KT&G has expanded into nicotine pouches through ASF. All three transactions involved multiple external professional-services firms.

As nicotine-pouch and modern oral assets become part of the acquisition portfolios of multinational tobacco companies, global law firms, Big Four firms and investment banks are increasingly appearing across the transaction chain.

Follow 2Firsts for timely coverage of global tobacco and nicotine M&A, capital markets and corporate strategy.

Cover Image generated by AI


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
Nasdaq-listed AIR Global has invested $20 million in preferred shares of Canadian vaporization technology company Greentank, deepening a partnership established in 2023. AIR gains a board nomination right, access to new technologies, enhanced commercial terms and long-term supply assurances, while retaining an option to increase its stake. Greentank’s Quantum Chip platform powers Crown Switch and forms part of AIR’s planned U.S. PMTA dossier, linking capital investment more closely with product technology, regulatory evidence and supply-chain control.
Special Report
Jul.29
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
Logista France says tobacco consumption outside France’s official tobacconist network has become a large and structural market phenomenon, but official and industry estimates differ sharply. France’s TAFE study estimates that 17.7% of tobacco consumption escaped domestic taxation in 2023, with most of that volume attributed to cross-border purchasing rather than street sales. Some industry studies use broader off-channel definitions and put the figure above 50%. Meanwhile, French Customs seized 547.94 tonnes of tobacco in 2025, up 12%, showing continued pressure from illicit trade.
Sep.04
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
Kumulus Vape, Europe’s first publicly listed vape company, reported a 7.8% year-on-year decline in first-half 2026 revenue. Amid changing conditions in France’s vape market, the company said channel diversification helped offset pressure, with physical store sales increasing 41.5% year on year. Listed on Euronext Access Paris in 2019 and later transferred to Euronext Growth Paris, Kumulus Vape is viewed as a representative company of Europe’s vape sector. Its performance highlights the industry’s shift from rapid expansion toward more operationally focused growth.
Jul.27
BAT's VELO Partners With McLaren F1 Team for Global Fan Campaign to Expand Nicotine Pouch Brand Reach
BAT's VELO Partners With McLaren F1 Team for Global Fan Campaign to Expand Nicotine Pouch Brand Reach
BAT-owned nicotine pouch brand VELO and the McLaren Mastercard Formula 1 Team have launched a global fan engagement campaign offering motorsport enthusiasts opportunities to win exclusive team-related experiences. The initiative aims to connect racing culture, fan interaction and VELO’s brand experience across global markets. The partnership reflects BAT’s broader strategy of expanding modern nicotine product brands beyond traditional tobacco categories through lifestyle and cultural marketing.
Jul.23